Scholarlink

Background <p>Patent ductus arteriosus (PDA) is a common congenital heart disease. While the <i>ACTC1</i> gene is crucial for heart development, the role of its promoter variants in PDA pathogenesis remains unclear.</p> Methods <p>Peripheral blood DNA from 745 subjects (427 PDA patients and 318 healthy controls) was sequenced. Functional assessments included transcriptional activity assays in mouse cardiomyocytes, electrophoretic mobility shift assays (EMSA), and JASPAR database analysis.</p> Results <p>Eight variants in the <i>ACTC1</i> promoter region were identified. Four of these, including a novel heterozygous variant, were found exclusively in PDA patients. These variants significantly altered <i>ACTC1</i> promoter transcriptional activity (p&lt;0.05). Furthermore, EMSA and JASPAR analyses indicated that these variants affect <i>ACTC1</i> transcription by destroying or generating transcription factor binding sites.</p> Conclusion <p>This study provides the first evidence associating <i>ACTC1</i> promoter variants with PDA occurrence, offering novel perspectives on the pathogenesis and potential therapeutic strategies for PDA.</p> <p></p> Impact <p><UnorderedList Mark="Bullet"> <ItemContent> <p>DNA from 745 human subjects was sequenced for <i>ACTC1</i> gene promoter region variants with four variants found only in PDA patients and one was novel.</p> </ItemContent> <ItemContent> <p>EMSA and dual luciferase reporter experiments found these variants reduced transcriptional activity.</p> </ItemContent> <ItemContent> <p>Prediction by JASPAR database indicated that these variants alter the transcription factor binding sites.</p> </ItemContent> <ItemContent> <p>The study, for the first time, confirmed that there are variants at the <i>ACTC1</i> gene promoter region and these variants cause cellular dysfunction.</p> </ItemContent> <ItemContent> <p>The variants found in this study suggest the possible pathological role in the formation of PDA.</p> </ItemContent> </UnorderedList></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Genetic variants of ACTC1 gene promoter in pediatric patients with sporadic patent ductus arteriosus and pathological significance

  • 期刊论文

  • 发表日期：

    2026年5月12日

查看全文
  • Zi-Fei Zheng,
  • Huan-Xin Chen,
  • Qin Yang,
  • Guo-Wei He

摘要

Background

Patent ductus arteriosus (PDA) is a common congenital heart disease. While the ACTC1 gene is crucial for heart development, the role of its promoter variants in PDA pathogenesis remains unclear.

Methods

Peripheral blood DNA from 745 subjects (427 PDA patients and 318 healthy controls) was sequenced. Functional assessments included transcriptional activity assays in mouse cardiomyocytes, electrophoretic mobility shift assays (EMSA), and JASPAR database analysis.

Results

Eight variants in the ACTC1 promoter region were identified. Four of these, including a novel heterozygous variant, were found exclusively in PDA patients. These variants significantly altered ACTC1 promoter transcriptional activity (p<0.05). Furthermore, EMSA and JASPAR analyses indicated that these variants affect ACTC1 transcription by destroying or generating transcription factor binding sites.

Conclusion

This study provides the first evidence associating ACTC1 promoter variants with PDA occurrence, offering novel perspectives on the pathogenesis and potential therapeutic strategies for PDA.

Impact

DNA from 745 human subjects was sequenced for ACTC1 gene promoter region variants with four variants found only in PDA patients and one was novel.

EMSA and dual luciferase reporter experiments found these variants reduced transcriptional activity.

Prediction by JASPAR database indicated that these variants alter the transcription factor binding sites.

The study, for the first time, confirmed that there are variants at the ACTC1 gene promoter region and these variants cause cellular dysfunction.

The variants found in this study suggest the possible pathological role in the formation of PDA.